Gain Therapeutics (GANX) Proxy Filing summary

Executive summary

• Annual meeting scheduled for June 24, 2025, at 8:30 a.m. EDT in New York.

• Stockholders of record as of April 25, 2025, are eligible to vote.

• Proxy materials are available online, with options to request paper or email copies by June 13, 2025.

Voting matters and shareholder proposals

• Election of eight director nominees is up for vote.

• Ratification of Ernst & Young AG as independent auditor for fiscal year ending December 31, 2025.

• Proposal to amend the certificate of incorporation to increase authorized common stock from 50,000,000 to 100,000,000.

• Proposal to approve adjournment of the meeting if more time is needed for Proposal 3.

• Proxy holders have discretionary authority to vote on other business or substitute nominees if needed.

Board of directors and corporate governance

• Board recommends voting "FOR" all director nominees and all proposals.

• Eight individuals are nominated for election to the board.